Table 2 Effects of AR training program on SCIM-SR, MSES, WST, CD-RISC (measured at T1: baseline; T2: completion of programme; T3: 3 months follow-up).
T1 | Difference T2-T1 | Difference T3-T1 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
n | Mean (95% CI) | n | Mean difference (95% CI) | Effect size (d) | Clinically important difference–small (%)b | n | Mean difference (95% CI) | Effect size (d) | Clinically important difference–small (%)b | |
SCIM Total score (0-100)a | 109 | 60.2 (56.8–63.5) | 108 | 2.9 (1.6–4.1)** | 0.8 | 39% | 103 | 2.2 (0.4–4.0)** | 0.4 | 34% |
Self-care (0-20)a | 15.4 (14.5–16.3) | 1.2 (0.8–1.7)** | 0.9 | 47% | 0.6 (-0.1–1.2) | 42% | ||||
Respiration and sphincter (0-40)a | 26.5 (25.1–27.9) | 0.8 (-0.1–1.7) | 34% | 0.9 (-0.4–2.1) | 31% | |||||
Mobility in room and toilet (0-10)a | 7.6 (7.1–8.1) | 0.3 (0.0–0.6)* | 0.4 | 30% | 0.6 (0.1–1.0)** | 0.5 | 37% | |||
Mobility indoors and outdoors on even surfaces (0-30)a | 10.6 (9.3–11.9) | 0.3 (-0.3–0.9) | 18% | 0.2 (-0.6–1.0) | 21% | |||||
Moorong Self-efficacy Scale (16-112)a | 111 | 5.4 (5.2–5.5) | 110 | 0.3 (0.2–0.4)** | 0.7 | 51% | 106 | 0.1 (-0.1–-0.3) | 40% | |
Social functiona | 5.8 (5.6–6.0) | 110 | 0.2 (0.1–0.4)** | 0.6 | 47% | 0.0 (-0.2–0.2) | 41% | |||
General self-efficacya | 5.3 (5.1–5.6) | 110 | 0.2 (0.1–0.4)** | 0.3 | 52% | 0.1 (-0.2–0.3) | 54% | |||
Personal functiona | 5.3 (5.0–5.5) | 110 | 0.3 (0.1–0.5)** | 0.6 | 37% | 0.2 (-0.1–0.4) | 40% | |||
WST-Q Capacity (0-100)a | 102 | 65.4 (61.0–69.8) | 104 | 8.2 (5.8–10.6)** | 1.2 | 59% | 88 | 7.1 (3.7–10.6)** | 0.7 | 59% |
WST-Q Confidence (0-100)a | 95 | 57.5 (52.7–62.3) | 99 | 8.4 (5.0–11.9)** | 0.8 | 65% | 78 | 7.3 (2.3 -12.2)** | 0.5 | 61% |
CD-RISC (0-100)a | 74 | 69.5 (65.4–73.7) | 73 | 5.1 (2.4–7.7)** | 0.7 | 68 | 2.0 (-5.7–1.7) |